Correction to: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease [0.03%]
Correction to：哪些成本重要？经济评价中包含的成本及其对稳定型冠心病决策不确定性的影晌
James Lomas,Miqdad Asaria,Laura Bojke et al.
James Lomas et al.
The original article can be found online.
Published Erratum
PharmacoEconomics - open. 2019 Jun;3(2):277. DOI:10.1007/s41669-019-0129-0 2019
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada [0.03%]
一周一次司美格鲁肽与一周一次度拉格鲁肽治疗加拿大2型糖尿病患者的成本效益分析
Pierre Johansen,Jonas Håkan-Bloch,Aiden R Liu et al.
Pierre Johansen et al.
Objective: The aim of this study was to assess the cost effectiveness of semaglutide versus dulaglutide, as an add-on to metformin monotherapy, for the treatment of type 2 diabetes (T2D), from a Canadian societal perspect...
Remote Monitoring of Patient-Reported Outcomes in Ulcerative Colitis: A Prospective Real-World Pilot Study [0.03%]
溃疡性结肠炎患者报告结果的远程监测：一项前瞻性真实世界试点研究
Shaji Sebastian,Jenna Roberts,John Waller et al.
Shaji Sebastian et al.
Introduction: The 6-point version of the Mayo score relies on two patient-reported outcomes (PRO2): stool frequency and rectal bleeding. We assessed the feasibility and acceptability of remote online PRO2 reporting for go...
A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa [0.03%]
血透与腹膜透析治疗终末期肾衰的成本分析——以南非比勒陀利亚一家教学医院为例
Letlhogonolo Makhele,Moliehi Matlala,Mncengeli Sibanda et al.
Letlhogonolo Makhele et al.
Background: Haemodialysis (HD) and peritoneal dialysis (PD) are commonly used treatments for the management of patients with end-stage renal disease (ESRD). The costs of managing these patients have grown in recent years ...
National Health Insurance Databases in Indonesia, Vietnam and the Philippines [0.03%]
印度尼西亚、越南和菲律宾的国家健康保险数据库
Junice Yi Siu Ng,Royasia Viki Ramadani,Donni Hendrawan et al.
Junice Yi Siu Ng et al.
Background: Social health insurance administrative databases were established in Indonesia, Vietnam and the Philippines in 2014, 2017 and 2012, respectively; however, these databases have been scarcely used for research, ...
Smart Pump-Electronic Health Record (EHR) Interoperability with Auto-Documentation is Associated with Increased Submission of Infusion-Therapy Billing Claims at a Community Hospital [0.03%]
智能泵与电子健康记录(EHR)的自动文档互操作性与社区医院输液治疗计费提交增加相关
Tina M Suess,John W Beard,Michael Ripchinski et al.
Tina M Suess et al.
Background: Smart pump-electronic health record (EHR) interoperability has been demonstrated to reduce adverse events and increase documentation and billing accuracy. However, relatively little is known about the impact o...
Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial [0.03%]
急性冠脉综合征患者以病人为中心的护理模式的成本效益分析：一项随机对照临床试验的次级研究
Laura Pirhonen,Kristian Bolin,Elisabeth Hansson Olofsson et al.
Laura Pirhonen et al.
Background: Costs associated with an ACS incident are most pronounced in the acute phase but are also considerably long after the initial hospitalisation, partly due to considerable productivity losses, which constitute a...
Associations between Health-Related Quality of Life and Self-Reported Emergency Room Department Visits and Inpatient Hospitalizations: Insights from a Secondary Data Analysis of Patients with Light-Chain (AL) Amyloidosis [0.03%]
健康相关生活质量与自述急诊和住院之间的联系：轻链(AL)型淀粉样变性患者的二次数据分析启示
Kristen L McCausland,Avery A Rizio,Michelle K White et al.
Kristen L McCausland et al.
Introduction: Light-chain (AL) amyloidosis is a rare, progressive, and typically fatal disease. Health-related quality of life (HRQoL) has been shown to be a significant prognostic factor associated with clinical outcomes...
Cost of Treatment of Valvular Heart Disease at a Tertiary Hospital in North India: Policy Implications [0.03%]
印度北部一家三级医院瓣膜性心脏病治疗费用及政策启示
Shankar Prinja,Yashpaul Sharma,Jyoti Dixit et al.
Shankar Prinja et al.
Background: Lack of data on the cost of cardiac care is an impediment to evidence-based planning, especially for determining provider payment rates under publically financed health insurance schemes. ...
Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal [0.03%]
用于治疗既往接受过一种化疗方案的局部晚期或转移性乳腺癌的艾日布林：NICE单一技术评估的证据审查组视角
Nigel Fleeman,Adrian Bagust,Rui Duarte et al.
Nigel Fleeman et al.
Eribulin is a recommended treatment option for locally advanced or metastatic breast cancer (LABC/MBC) in adults whose disease has progressed after at least two chemotherapy regimens. The National Institute for Health and Care Excellence (N...